Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493703 | 12649370 | 3 | F | 201604 | 20160826 | 20160812 | 20160906 | EXP | GB-PFIZER INC-2016373973 | PFIZER | 41.00 | YR | F | Y | 0.00000 | 20160906 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493703 | 12649370 | 1 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 126493703 | 12649370 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 126493703 | 12649370 | 3 | PS | DOCETAXEL. | DOCETAXEL | 1 | UNK | U | 202356 | ||||||||||
| 126493703 | 12649370 | 4 | SS | EPIRUBICIN HCL | EPIRUBICIN HYDROCHLORIDE | 1 | UNK | U | 50778 | ||||||||||
| 126493703 | 12649370 | 5 | SS | PALONOSETRON HYDROCHLORIDE. | PALONOSETRON HYDROCHLORIDE | 1 | UNK | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 126493703 | 12649370 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 245 DF, UNK | U | 0 | 245 | DF | |||||||
| 126493703 | 12649370 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | UNK | U | 0 | ||||||||||
| 126493703 | 12649370 | 8 | SS | TAXOTERE | DOCETAXEL | 1 | UNK | U | 0 | ||||||||||
| 126493703 | 12649370 | 9 | SS | APREPITANT. | APREPITANT | 1 | Oral | 168 DF, UNK | U | 0 | 168 | DF | |||||||
| 126493703 | 12649370 | 10 | SS | DOMPERIDONE | DOMPERIDONE | 1 | UNK | U | 0 | ||||||||||
| 126493703 | 12649370 | 11 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126493703 | 12649370 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126493703 | 12649370 | Alopecia | |
| 126493703 | 12649370 | Condition aggravated | |
| 126493703 | 12649370 | Ear discomfort | |
| 126493703 | 12649370 | Epistaxis | |
| 126493703 | 12649370 | Fatigue | |
| 126493703 | 12649370 | Haemoglobin decreased | |
| 126493703 | 12649370 | Infusion site erythema | |
| 126493703 | 12649370 | Infusion site pruritus | |
| 126493703 | 12649370 | Infusion site vesicles | |
| 126493703 | 12649370 | Joint swelling | |
| 126493703 | 12649370 | Limb discomfort | |
| 126493703 | 12649370 | Neuropathy peripheral | |
| 126493703 | 12649370 | Oedema peripheral | |
| 126493703 | 12649370 | Pain in extremity | |
| 126493703 | 12649370 | Peripheral swelling | |
| 126493703 | 12649370 | Pyrexia | |
| 126493703 | 12649370 | Rosacea | |
| 126493703 | 12649370 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126493703 | 12649370 | 3 | 20160602 | 0 | ||
| 126493703 | 12649370 | 7 | 20160603 | 0 | ||
| 126493703 | 12649370 | 8 | 20160602 | 0 |